DWA
STIM icon

Dorsey Wright & Associates’s Neuronetics STIM Stock Holding History

Dorsey Wright & Associates’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,500
Closed -$17K – 367
2020
Q4 		$17K Buy
+1,500
New +$11.3K ﹤0.01% 197

Other funds holding STIM

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Dorsey Wright & Associates's STIM Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of Neuronetics (STIM) in Q1 2021, closing a stake of 1,500 shares — an estimated $17K sold.

Dorsey Wright & Associates first reported a position in STIM in Q4 2020 and held it in 1 quarter. The position peaked at $17K in Q4 2020. 83 funds tracked by Wall St. Rank hold STIM as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining Neuronetics position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,500 Neuronetics shares in Q1 2021, an estimated $17K.
  • Dorsey Wright & Associates first reported a position in Neuronetics in Q4 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Neuronetics position peaked at $17K in Q4 2020.
  • 83 funds tracked by Wall St. Rank held Neuronetics as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.